Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00116480Not ApplicableCompleted

Misoprostol in the Treatment of Postpartum Hemorrhage

Role: collaborator

NCT00120237Not ApplicableCompleted

Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan

Role: collaborator

NCT00116350Not ApplicableCompleted

Misoprostol for the Treatment of Postpartum Hemorrhage

Role: collaborator

NCT00124540Not ApplicableCompleted

Misoprostol for Preventing Postpartum Hemorrhage

Role: collaborator

All 4 trials loaded